Agnieszka Fitas

Agnieszka Fitas

Auto-generated profile, based on publicly available information

Agnieszka Fitas

4th Clinical University Hospital in Lublin, Lublin, Poland

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 September 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
WGWojciech Gąska
Wojciech Gąska
JGJulia Głowacka
Julia Głowacka
MSMathias Spitaleri
Mathias Spitaleri
FKFilip Kieloch
Filip Kieloch
DSDawid Sewruk
Dawid Sewruk
KDKarolina Dębek
Karolina Dębek
Background: Type 2 diabetes mellitus (T2DM) is a progressive metabolic disorder strongly linked to modifiable lifestyle factors. Lifestyle medicine provides a multidomain, evidence-based framework for prevention and management of T2DM and its complications. Objective: This narrative review synthesizes evidence on six lifestyle medicine domains—diet, physical activity, sleep, smoking cessation, stress management, and social support—in improving glycemic control, insulin sensitivity, and overall health in adults with T2DM. Methods: A PubMed search was conducted using keywords including “type 2 diabetes,” “lifestyle medicine,” “diet,” “physical activity,” “sleep,” “smoking cessation,” “stress,” “mindfulness,” and “social support.” Peer-reviewed English-language studies were prioritized, emphasizing systematic reviews, meta-analyses, randomized controlled trials, and large cohort studies. Relevant guidelines and professional society reports were also reviewed. Results: Carbohydrate-restricted, low-glycemic-index, and Mediterranean diets reduced HbA1c by 0.7–1.8% and fasting glucose by up to 1.3 mmol/L. Aerobic plus resistance training improved HbA1c (~0.7%), HOMA-IR, and VO₂ peak. Optimal sleep (7–8 h) correlated with better glycemic control, while short or long durations worsened HbA1c by 0.2–0.3%. Smoking impaired insulin sensitivity and β-cell function, whereas cessation reduced cardiovascular risk. Stress reduction and mindfulness programs lowered HbA1c by ~0.3% and improved mental health. Social interventions, including structured education and peer support, decreased HbA1c by ~0.25% and reduced isolation-related risks. Conclusion: Lifestyle medicine offers synergistic, non-pharmacological strategies that enhance glycemic control, slow T2DM progression, and improve quality of life. Incorporating these interventions into routine practice is crucial for comprehensive diabetes care.

19 September 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
WGWiktor Gąska
Wiktor Gąska
AFAgnieszka Fitas
Agnieszka Fitas
WGWojciech Gąska
Wojciech Gąska
JGJulia Głowacka
Julia Głowacka
MSMathias Spitaleri
Mathias Spitaleri
KDKarolina Dębek
Karolina Dębek
Objective: Telemedicine, defined as the distribution of health-related services and information via telecommunication technologies, has rapidly evolved from a niche solution into a central component of modern healthcare systems. As healthcare systems around the world contend with the challenges of aging populations, a rise in chronic diseases, and a growing shortage of healthcare professionals, telemedicine could be an effective solution, offering innovative ways to expand access to care, enhance patient outcomes and optimize resource use. The aim of this review is to critically explore and evaluate the role of telemedicine in modern healthcare services, with a specific focus on its applications in managing chronic diseases, acute care, and mental health services. This study seeks to analyze the benefits, challenges, and limitations associated with the widespread adoption of telemedicine. Methods: The article is the result of review of recent scientific literature using PubMed database. Literature was reviewed using keywords. Key findings: In recent years, telemedicine has demonstrated significant benefits in enhancing healthcare delivery, particularly in chronic disease management, acute care, and mental health services. Evidence shows improved patient outcomes, reduced hospitalizations, and greater accessibility for underserved populations. The COVID-19 pandemic accelerated telemedicine adoption, highlighting its value in ensuring continuity of care and fostering technological innovation, such as AI-driven diagnostics and remote monitoring. Despite these advantages, barriers such as the digital divide, regulatory challenges, and limitations in conducting physical examinations persist. Conclusion: Telemedicine has rapidly become an integral component of modern healthcare, offering significant benefits in chronic disease management, acute care, and mental health services. The flexibility and accessibility it provides have proven invaluable, particularly during the COVID-19 pandemic, where it ensured continuity of care while minimizing risks. With continued innovation and thoughtful integration, telemedicine is poised to play a crucial role in the future of healthcare, enhancing patient outcomes and expanding access to essential services, despite its challenges.

8 September 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
FKFilip Kieloch
Filip Kieloch
AFAgnieszka Fitas
Agnieszka Fitas
KKKarol Kanon
Karol Kanon
MSMathias Spitaleri
Mathias Spitaleri
WGWiktor Gąska
Wiktor Gąska
KDKarolina Dębek
Karolina Dębek
Introduction: Androgenetic alopecia (AGA) is a chronic progressive form of hair loss affecting a significant portion of the adult population. Although topical minoxidil has a proven efficacy, it is often associated with low adherence due to adverse effects and the inconvenience of use. Increasing attention is being paid to low-dose oral minoxidil (LDOM), which may represent a therapeutic alternative with a favorable safety profile. Purpose of The Work: The aim of this study was to assess the efficacy and safety of low-dose oral minoxidil (≤5 mg/day) in the treatment of androgenetic alopecia based on current clinical trial data. Material and Methods: A narrative literature review was conducted, including studies published in English between 2019 and 2024, concerning the efficacy and safety in patients with AGA. A total of 9 publications meeting the inclusion criteria were analyzed. Results: The analyzed studies demonstrated that LDOM increases both the number and diameter of hair in patients – in both men and women. The best results were observed at doses of 1-5 mg/day, although even very low doses (0.25 mg/day) yielded measurable effects. Adverse events were generally mild – most commonly hypertrichosis and cardiovascular symptoms (e.g., tachycardia), with incidence increasing with dose. Serious complications were rare and occurred primarily in patients with pre-existing heart disease. Conclusion: Low-dose oral minoxidil is an effective and well-tolerated treatment option for AGA. Further studies are needed to standarize dosing and assess the long-term safety of the therapy.

25 September 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
OSOskar Sienkiel
Oskar Sienkiel
AFAgnieszka Fitas
Agnieszka Fitas
WGWojciech Gąska
Wojciech Gąska
JGJulia Głowacka
Julia Głowacka
MSMathias Spitaleri
Mathias Spitaleri
KDKarolina Dębek
Karolina Dębek
Introduction: Erectile dysfunction (ED), or impotence, is a condition where a man can't get or keep an erection firm enough for satisfying sexual intercourse. It affects men of all ages and is caused by a variety of physical, psychological, or social factors. The number of ED cases is growing annually, and treatment costs are rising steadily. This combination of increasing prevalence and rising expenses highlights the need for a highly optimized treatment method. Efforts should focus on finding a solution that is as effective as possible while also being cost-efficient. The goal is to provide accessible, high-quality care without the financial burden, ensuring that men who suffer from this condition can find relief and improve their quality of life. The search for such a method is crucial given the growing impact of ED on men worldwide. Aim: The aim of this study was to review literature studies on ED and methods for treating this condition. Method: Data for the article were retrieved by using Pub Med setting the time descriptor to 2020-2025. Conclusions: Despite the availability of many effective treatments for erectile dysfunction (ED), it can still be a challenging condition due to the variety of underlying causes. Therefore, an individualized approach and thorough diagnostics are essential. Regenerative therapies and shockwave therapy, although still experimental, offer new therapeutic opportunities. In the future, it will be important to conduct randomized studies with long-term follow-up to assess the effectiveness and safety of these new methods.

25 September 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
MSMathias Spitaleri
Mathias Spitaleri
KKKarol Kanon
Karol Kanon
FKFilip Kieloch
Filip Kieloch
JGJulia Głowacka
Julia Głowacka
AFAgnieszka Fitas
Agnieszka Fitas
DSDawid Sewruk
Dawid Sewruk
Chronic pain is a pervasive and debilitating condition that affects millions of individuals worldwide. Traditional methods of pain management, including the use of opioids, often fall short in providing adequate relief and come with significant risks, such as dependency and tolerance. As a result, there has been growing interest in exploring alternative treatments, with ketamine emerging as a promising option. Ketamine, a dissociative anesthetic, has shown potential in alleviating various types of chronic pain, including neuropathic pain, cancer-related pain, and pain associated with complex regional pain syndrome (CRPS). Aim of study: This review aims to examine the current evidence on the efficacy of ketamine in chronic pain management, exploring its mechanisms of action, clinical applications, safety profile, and potential limitations. Methods and materials: PubMed and Scopus databases were used to search for topic treated articles.

30 September 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
JKJulia Konat
Julia Konat
JNJan Noskowicz
Jan Noskowicz
JUJan Urban
Jan Urban
WDWiktor Doroszuk
Wiktor Doroszuk
DSDawid Sewruk
Dawid Sewruk
AFAgnieszka Fitas
Agnieszka Fitas
Background: Polycystic Ovary Syndrome (PCOS) is a common endocrine disorder affecting up to 10% of reproductive-aged women. Beyond reproductive symptoms, PCOS is increasingly associated with mental health challenges, including depression, anxiety, and stress, often overlooked in routine care. Aim: This study assessed the prevalence and severity of psychological symptoms in women with PCOS and identified clinical and behavioral predictors of poor outcomes, with emphasis on modifiable lifestyle factors. Methods: A cross-sectional study was conducted among 200 women aged 18–40 diagnosed with PCOS by Rotterdam criteria. Participants completed the Depression, Anxiety and Stress Scale-21 (DASS-21) and a survey on sleep, physical activity, nutrition, and social support. Clinical indicators included BMI, menstrual regularity, hirsutism, and acne. Pearson correlations and regression models were used to analyze associations. Results: Moderate to severe depression affected 62% of participants, elevated anxiety 54%, and high stress 38%. Higher BMI, irregular cycles, and hirsutism were strongly correlated with worse psychological scores. Protective factors included regular physical activity, sufficient sleep, and positive body image. Regression analyses confirmed both clinical and behavioral predictors were significant (p < 0.05). Conclusions: Women with PCOS experience a substantial psychological burden. Routine care should integrate mental health screening and multidisciplinary management. Lifestyle interventions focusing on exercise, sleep, and body image may significantly improve emotional well-being and overall quality of life.